A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
IntroductionHepatocellular carcinoma (HCC) ranks among the three most prevalent cancer-related diseases in terms of incidence. Hence, exploring drugs for HCC therapy is of great significance. Compounds with a diaryl urea structure have been reported to exhibit a broad range of biological activities,...
Saved in:
| Main Authors: | Yue Fu, Weiyue Fang, Fuqiang Qiu, Juncai Lai, Yangjin Xu, Bin Chen, Yang Li, Xiaohui Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1605515/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01) -
Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01) -
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib
by: André Schreiber, et al.
Published: (2025-12-01) -
ELABELA targets the MEK/ERK axis to enhance trophoblast invasion in early-onset preeclampsia
by: Lijing Wang, et al.
Published: (2025-08-01) -
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway
by: Jun Wang, et al.
Published: (2020-10-01)